1. Home
  2. PACS vs ALKS Comparison

PACS vs ALKS Comparison

Compare PACS & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PACS
  • ALKS
  • Stock Information
  • Founded
  • PACS 2013
  • ALKS 1987
  • Country
  • PACS United States
  • ALKS Ireland
  • Employees
  • PACS N/A
  • ALKS N/A
  • Industry
  • PACS
  • ALKS Biotechnology: Pharmaceutical Preparations
  • Sector
  • PACS
  • ALKS Health Care
  • Exchange
  • PACS Nasdaq
  • ALKS Nasdaq
  • Market Cap
  • PACS 4.9B
  • ALKS 4.4B
  • IPO Year
  • PACS 2024
  • ALKS 1991
  • Fundamental
  • Price
  • PACS $17.49
  • ALKS $28.17
  • Analyst Decision
  • PACS Strong Buy
  • ALKS Buy
  • Analyst Count
  • PACS 9
  • ALKS 12
  • Target Price
  • PACS $39.44
  • ALKS $35.42
  • AVG Volume (30 Days)
  • PACS 2.6M
  • ALKS 1.9M
  • Earning Date
  • PACS 11-07-2024
  • ALKS 10-24-2024
  • Dividend Yield
  • PACS N/A
  • ALKS N/A
  • EPS Growth
  • PACS 82.79
  • ALKS 55.25
  • EPS
  • PACS 0.68
  • ALKS 1.97
  • Revenue
  • PACS $3,558,953,000.00
  • ALKS $1,505,121,000.00
  • Revenue This Year
  • PACS $29.04
  • ALKS N/A
  • Revenue Next Year
  • PACS $18.31
  • ALKS N/A
  • P/E Ratio
  • PACS $25.57
  • ALKS $12.33
  • Revenue Growth
  • PACS 205.08
  • ALKS N/A
  • 52 Week Low
  • PACS $16.74
  • ALKS $22.22
  • 52 Week High
  • PACS $43.92
  • ALKS $32.88
  • Technical
  • Relative Strength Index (RSI)
  • PACS N/A
  • ALKS 49.75
  • Support Level
  • PACS N/A
  • ALKS $28.10
  • Resistance Level
  • PACS N/A
  • ALKS $30.30
  • Average True Range (ATR)
  • PACS 0.00
  • ALKS 0.84
  • MACD
  • PACS 0.00
  • ALKS 0.11
  • Stochastic Oscillator
  • PACS 0.00
  • ALKS 50.32

About PACS PACS Group Inc. Common Stock

PACS Group Inc is a post-acute healthcare company primarily focused on delivering high-quality skilled nursing care through a portfolio of independently operated facilities Its is a nursing providers in the United States based on number of facilities, with over 200 post-acute care facilities across nine states serving over 20,000 patients daily. It also provide senior care, assisted living, and independent living options in some of communities.

About ALKS Alkermes plc

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

Share on Social Networks: